OpenBilldrug price receipt

NADAC week of 2026-10-14

BUPIVACAINE 0.25% VIAL

For 50 mL

Pharmacies pay

$2.40 filed

50 × $0.04792 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$2.50 derived

50 × $0.05 per ML, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

1.0× estimated

Medicare pays about what pharmacies pay.

13 labelers share HCPCS J0665 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-05-20 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$7.76 estimated

$2.40 + $0.36 (15%) + $5.00 fee per fill = $7.76

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-05-20 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUPIVACAINE 0.25% VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bupivacaine hydrochloride, under the trade name “Bupivacaine HCl”.

FDA gives its dosage form as injection, solution and its route as “infiltration; perineural” and “perineural”.

Its labelers, the companies named on the label, are Somerset Therapeutics, LLC, Xellia Pharmaceuticals USA LLC and Meitheal Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Amide Local Anesthetic.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes); the FDA directory lists 3 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.40 for 50 mL (50 × $0.04792 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-05-20. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of all 5 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-05-20. The file is new; the price is not.

All 5 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name bupivacaine hydrochloride with BUPIVACAINE 0.25% VIAL.

ProductPharmacies pay per unitMedicare per unit
BUPIVACAINE 0.25% VIAL this page
generic · injection, solution
$0.04792 per ML filed
eff. 2026-05-20
$0.05 per ML derived
Part B limit 2026 Q4
BUPIVACAINE 0.5% VIAL
generic · injection, solution
$0.08596 per ML filed
eff. 2026-04-22
$0.10 per ML derived
Part B limit 2026 Q4

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-05-20 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $0.04792 per ML filed.

Of the 21 other products in FDA’s Amide Local Anesthetic class priced per ML, 21 have a higher middle NADAC price and 0 a lower one. The one in the middle is LIDOCAINE 1%-EPI 1:100,000, at $0.13908 per ML filed (eff. 2026-07-22).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-07-22 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part B’s payment limit for HCPCS J0665, for 2026-10-01 to 2026-12-31, comes to $2.50 for 50 mL, or $0.05 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.002 per 0.5 MG.

2 of the product’s 5 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 50 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 50 mL in one package for the 3 of this product’s 5 NDCs it lists (“1 VIAL in 1 CARTON (70069-752-01) / 50 mL in 1 VIAL”), so the card starts at one package: 50 ML. Change it to match your prescription.